Minireviews
Copyright ©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Figure 5
Figure 5 Summary of the main etiologic agents and types of posttransplant thrombotic microangiopathy and their treatment and preventive strategies. CFB: Complement factor B; CFH: Complement factor H; CNI: Calcineurin inhibitor; IVIG: Intravenous immunoglobulin; mTOR: Mammalian target of rapamycin; TTP: Thrombotic thrombocytopenic purpura.